Literature DB >> 16889753

K-Ras4B proteins are expressed in the nucleolus: Interaction with nucleolin.

Maria C Birchenall-Roberts1, Tao Fu, Soo-Gyung Kim, Ying K Huang, Michael Dambach, James H Resau, Francis W Ruscetti.   

Abstract

Kirsten Ras4B (K-Ras4B) is a potent onco-protein that is expressed in the majority of human cell types and is frequently mutated in carcinomas. K-Ras4B, like other members of the Ras family of proteins, is considered to be a cytoplasmic protein that must be localized to the plasma membrane for activation. Here, using confocal microscopy and biochemical analysis, we show that K-Ras4B, but not H-Ras or the closely related K-Ras4A, is also present in the nucleoli of normal and transformed cells. Subcellular fractionation and immunostaining show that K-Ras4B is located not only in the cytoplasm, but also in the nucleolar compartment. Modification of a C-terminal hexa-lysine motif unique to K-Ras4B results in exclusively cytoplasmic forms of the protein. Nucleolin, a pleiotropic regulator of cellular processes, including transcriptional regulation, is also characterized by a nucleolar-like nuclear appearance. We show that K-Ras4B and nucleolin co-localize within the nucleus and that nucleolin physically associates with K-Ras4B. Inhibition of K-Ras4B/nucleolin association blocked nucleolar localization of K-Ras4B. Using siRNA to knockdown the expression of nucleolin eliminated the nucleolar localization of K-Ras4B and significantly repressed the activation of the well-characterized K-Ras4B transcriptional target Ap-1, but stimulated Elk1. These data provide evidence of a nucleolar localization of K-Ras4B and describe a functional association between K-Ras4B and nucleolin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889753     DOI: 10.1016/j.bbrc.2006.07.094

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Molecular Simulations of Solved Co-crystallized X-Ray Structures Identify Action Mechanisms of PDEδ Inhibitors.

Authors:  Ramin Ekhteiari Salmas; Mert Mestanoglu; Mine Yurtsever; Sergei Y Noskov; Serdar Durdagi
Journal:  Biophys J       Date:  2015-09-01       Impact factor: 4.033

2.  Arachidonic acid stimulates formation of a novel complex containing nucleolin and RhoA.

Authors:  Melissa C Garcia; Jason Williams; Katina Johnson; Kenneth Olden; John D Roberts
Journal:  FEBS Lett       Date:  2011-02-01       Impact factor: 4.124

3.  Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction.

Authors:  Kerry L Inder; Chiyan Lau; Dorothy Loo; Natasha Chaudhary; Andrew Goodall; Sally Martin; Alun Jones; Dharini van der Hoeven; Robert G Parton; Michelle M Hill; John F Hancock
Journal:  J Biol Chem       Date:  2009-08-06       Impact factor: 5.157

4.  PNRC accumulates in the nucleolus by interaction with B23/nucleophosmin via its nucleolar localization sequence.

Authors:  Yuanzhong Wang; Bin Chen; Yuping Li; Dujin Zhou; Shiuan Chen
Journal:  Biochim Biophys Acta       Date:  2010-10-01

5.  H-ras localizes to cell nuclei and varies with the cell cycle.

Authors:  Sara Contente; Tze-Jou Annie Yeh; Robert M Friedman
Journal:  Genes Cancer       Date:  2011-02

6.  Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation.

Authors:  E Merit Reyes-Reyes; Francesca R Šalipur; Mitra Shams; Matthew K Forsthoefel; Paula J Bates
Journal:  Mol Oncol       Date:  2015-04-09       Impact factor: 6.603

7.  The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin.

Authors:  Sherwin J Abraham; Ryan P Nolet; Richard J Calvert; Lucy M Anderson; Vadim Gaponenko
Journal:  Biochemistry       Date:  2009-08-18       Impact factor: 3.162

8.  Analysis of k-ras nuclear expression in fibroblasts and mesangial cells.

Authors:  Isabel Fuentes-Calvo; Ana M Blázquez-Medela; Eugenio Santos; José M López-Novoa; Carlos Martínez-Salgado
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

9.  Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.

Authors:  Hirota Fujiki; Tatsuro Watanabe; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-28       Impact factor: 4.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.